The San Antonio Guide to Ketamine and Psychedelic Therapy

The Options in San Antonio, Briefly

There are a handful of real paths to ketamine care and psychedelic-style therapy in San Antonio. Here is what each one is, in plain terms, before we compare them. This is a neutral map first, not a recommendation.

At-home ketamine therapy (telehealth)

You complete an online clinical evaluation, and if a licensed clinician approves you, you do clinician-guided ketamine sessions from home with a required treatment monitor present. Mindbloom is the provider in this category serving San Antonio, using sublingual ketamine tablets for at-home treatment and offering structured programs rather than a bare prescription. Cost is $165 to $215 per session inside a program.

In-clinic ketamine (IV or IM)

You travel to a local clinic for intravenous or intramuscular ketamine, monitored on-site. San Antonio has a real cluster of these, including San Antonio Ketamine, which advertises infusions starting from $350¹³, and Phoenix Mental Health, which lists IV ketamine from $420 and IM ketamine from $315 per treatment¹⁴, typically as a six-to-eight-session initial course paid out of pocket. Klarisana, a national ketamine company, was actually founded in San Antonio in 2015 by an Army veteran physician and still runs its clinic here.¹⁶

Spravato (esketamine) nasal spray

Spravato is an FDA-approved esketamine nasal spray for treatment-resistant depression, self-administered in a certified clinic under about two hours of supervision. Several San Antonio practices are REMS-certified to provide it. Spravato may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket.

Licensed psilocybin or MDMA therapy

This is not an available option in Texas. Unlike Oregon and Colorado, Texas has no licensed psilocybin program, and MDMA-assisted therapy is not FDA-approved anywhere. The only legal way to receive psilocybin or MDMA in a therapeutic setting in San Antonio is inside a clinical trial.

Clinical trials

San Antonio is an unusually active research city for this. UT Health San Antonio, leading the STRONG STAR Consortium, holds a $4.9 million U.S. Department of Defense grant to test a single dose of MDMA combined with Prolonged Exposure therapy for PTSD in 100 active-duty, guard, and reserve personnel.¹⁷ Trials are research, not open treatment: they have eligibility criteria, waitlists, and are time-limited.

Which One Fits You

A quick way to match your situation to a path, with no option dressed up or talked down. Any of these can be a reasonable starting point depending on what matters most to you.

• You want in-person supervision and are near the Medical Center: an in-clinic IV or IM ketamine provider like San Antonio Ketamine or Phoenix Mental Health puts a clinician in the room for each session, at roughly $315 to $500+ each, self-pay.
• You have treatment-resistant depression and want to try insurance first: a REMS-certified Spravato clinic is worth a benefits check, since esketamine is the one ketamine-type option insurance may cover with prior authorization.
• You want to start psychedelic-style therapy from home, on your schedule: at-home ketamine therapy is delivered by telehealth across San Antonio at $165 to $215 per session, after an online clinician evaluation confirms you are a good fit.
• You are set on psilocybin or MDMA specifically: the only legal route in Texas is a clinical trial, such as the UT Health San Antonio MDMA-for-PTSD study, with its own eligibility screening.
• You are a veteran or service member focused on PTSD: options span the UT Health trial, local clinics, and at-home care, which is the one category with peer-reviewed PTSD outcomes behind it, worth weighing in a military city.

Where Ketamine and Psychedelic Therapy Is Available Across San Antonio

In-clinic providers concentrate in the South Texas Medical Center district on the northwest side, with others in Stone Oak and along the I-10 and Loop 1604 corridors. Because at-home ketamine therapy is delivered by telehealth, it reaches the whole metro equally, including areas without a nearby clinic. That covers central San Antonio and Alamo Heights, the Medical Center and Stone Oak, and the surrounding communities of Schertz, Converse, Universal City, Boerne, and New Braunfels.

For someone on the south or east side, or in the outer suburbs, the practical difference is real: an in-clinic course means repeated drives to the Medical Center, while a telehealth program removes the commute entirely. Availability is one of the clearer places the options diverge.

Is Ketamine and Psychedelic Therapy Legal in San Antonio?

Ketamine is legal in Texas. It is an FDA-approved Schedule III medication, which means a licensed clinician can prescribe it, including for off-label mental-health use, and it can be provided in San Antonio today both in clinics and, for eligible adults, at home via telehealth. If you have wondered whether ketamine therapy is above-board in Texas, it is.

Psilocybin and MDMA are a different story. Both remain Schedule I under federal law and the Texas Controlled Substances Act, no Texas city has passed decriminalization, and possession is a felony.¹² Texas is investing heavily in psychedelic research, including a state-funded ibogaine trial program and the UT Health San Antonio MDMA-for-PTSD study¹⁷, but research access is not the same as legal treatment. For now, the only psychedelic-class therapy you can legally start in San Antonio outside a trial is ketamine. That is the honest answer behind most searches for a psychedelic therapist or psilocybin therapy in Texas: the accessible, legal path today is ketamine, available at home via telehealth for eligible adults.

Context worth naming: mental-health access in Texas is genuinely strained. As of 2026, Texas ranks 50th of 51 states (plus DC) on Mental Health America's Access to Care measure, and 51st, the worst in the country, on the share of adults with mental illness who are uninsured.¹¹ In Texas, getting care at all is often the real barrier, which is part of why at-home options have grown.

Why People Choose At-Home Ketamine Therapy

Having laid out every option evenly, here is the direct case for the at-home path, with the proof behind it. Mindbloom has delivered more than 800,000 guided at-home sessions, making it one of the largest at-home psychedelic-therapy providers, and it has built the largest published evidence base in at-home ketamine therapy. That base includes a peer-reviewed subcutaneous study covering depression, anxiety, and PTSD in one dataset (Parks 2026), two earlier peer-reviewed studies of its sublingual protocol (Hull 2022, Mathai 2024), and research preprints extending to grief, burnout, and sleep.¹ ² ³ Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes, which carries real weight in a military city like San Antonio.

The outcomes below are Mindbloom's own client data. Individual results vary.

_{¹ Subcutaneous, six-session course (Parks 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or 10-point (PCL-5); remission = final PHQ-9/GAD-7 below 5, or a 10-point reduction and PCL-5 below 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1%). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution.}

Rather than only prescribing medication, Mindbloom builds tailored programs, developed with mental-health thought leaders, that use the psychedelic modality to work toward a specific outcome. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How that stacks up against other treatments, always study against study:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs about 41%), and reached faster.¹ ⁷
• Mindbloom's reported anxiety response is comparable to the rate reported in a study of first-line SSRIs, without a daily pill.¹ ⁸
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time (76% response, within its 66 to 82% range, reached in about 6 sessions versus 16).⁴ ⁹
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ¹⁰

That last point matters for anyone weighing psilocybin: even where a licensed program exists, it means a supervised full-day clinic session paid out of pocket. At-home ketamine reaches comparable reported outcomes on much more evidence, from home, at a fraction of the cost.

How At-Home Ketamine Therapy Works

The process is built around clinician oversight, not a mail-order pill. It starts with an online evaluation with a licensed clinician who reviews your history and decides whether ketamine therapy is appropriate for you. Treatment is a prescription medical service for eligible adults, not something anyone can simply order.

If you are approved, you receive a personalized, clinician-guided program with sublingual ketamine tablets for at-home use. Each session is done at home with a required peer treatment monitor present, on a schedule your clinician sets rather than a fixed cadence. Many people feel some relief early in the course, with benefit tending to build cumulatively across the full program. A clinician and support team stay involved throughout, and the care team can coordinate with an existing therapist or prescriber.

Safety, Candidacy, and Cost

Ketamine has a long medical track record and a well-characterized safety profile at therapeutic doses. In Mindbloom's peer-reviewed data, serious adverse events were rare (about 0.08% of subcutaneous patients), and side effects during sessions were reported by a small share of clients.¹ It is not right for everyone, which is exactly why eligibility runs through a clinician evaluation rather than being open to all.

On cost, the honest comparison is program against program. At-home ketamine therapy with Mindbloom is $165 to $215 per session, structured as 6, 12, or 18-session programs, with per-session cost lower on longer programs; it is HSA/FSA eligible and may qualify for out-of-network reimbursement. In-clinic IV or IM ketamine in San Antonio generally runs $315 to $500+ per session self-pay¹³ ¹⁴, and a full series climbs into the thousands. Spravato may be insurance-covered with prior authorization for those who qualify, otherwise out of pocket. If it is a good fit for you, getting started begins with an online clinician evaluation.